Pharmacokinetics and pharmacodynamics of moist snuff in humans

Tobacco Control

Volumn 8, Issue 4, 1999, Pages 387-392

  Fant, Reginald V ^a,b   Henningfield, Jack E ^a   Nelson, Richard A ^a   Pickworth, Wallace B ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b PINNEY ASSOCIATES   (United States)

Author keywords

Cardiovascular effects; Nicotine absorption; Snuff

Indexed keywords

NICOTINE;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG EFFECT; HEART RATE; HUMAN; MALE; MIDDLE AGED; PLANT; SMOKELESS TOBACCO;

ADULT; BLOOD PRESSURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PLANTS, TOXIC; TOBACCO, SMOKELESS;

EID: 0033252743     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.8.4.387     Document Type: Article

References (17)

1. US Department of Health and Human Services. National survey results on drug use from the Monitoring the Future Study, 1995-1997, Volume 1. Secondary school students. Johnston LD, O'Malley PM, Bachman JG, eds. Rockville, Maryland: National Institute on Drug Abuse, 1998:422.
2. Tomar SL, Winn DM, Swango GA, et al. Oral mucosal smokeless tobacco lesions among adolescents in the United States. J Dent Res 1997;76:1277-86.
3. US Department of Health and Human Services. The health consequences of using smokeless tobacco. A report of the advisory committee to the Surgeon General. Bethesda, Maryland: Public Health Service, National Institutes of Health, 1986. (NIH Publication No 86-2874.)
4. Tomar SL, Winn DM. Coronal and root caries among US adult users of chewing tobacco. J Dent Res 1998;77(special issue A):256 [abstract 1205].
5. US Department of Health and Human Services. Preventing tobacco use among young people. A report of the Surgeon General, 1994. Atlanta, Georgia: Public Health Service, Centers for Disease Control and Prevention, Office on Smoking and Health, 1994. (US Government Printing Office Publication No S/N 017-001-00491-0.)
6. Tomar SL, Henningfield JE. Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobacco. Tobacco Control 1997;6:219-25.
7. Henningfield JE, Fant RV, Tomar SL. Smokeless tobacco: an addicting drug. Adv Dent Res 1997;11:330-5.
8. Henningfield JE, Radzius A, Cone EJ. Estimation of available nicotine content of six smokeless tobacco products. Tobacco Control 1995;4:57-61.
9. Beckett AH, Gorrod JW, Jenner P. A possible relationship between pKa1 and lipid solubility and the amounts excreted in urine of some tobacco alkaloids given to man. J Pharm Pharmacol 1972;24:115-20.
10. Henningfield JE, Radzius A, Cooper TM, et al. Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum. JAMA 1990;264:1560-4.
11. Benowitz NL, Porchet H, Sheiner L, et al. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 1988;44:23-8.
12. Boyle RG, Jensen J, Hatsukami DK. Measuring dependence in smokeless tobacco users. Addict Behav 1995;20:443-50.
13. Holm H, Jarvis MJ, Russell MAH, et al. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology 1992;108:507-11.
14. US Department of Health and Human Services. The health consequences of smoking: nicotine addiction. A report of the Surgeon General, 1988. Rockville, Maryland: Public Health Service, Centers for Disease Control, Office on Smoking and Health, 1988. (DHHS Publication No (CDC) 88-8406.)
15. Connolly GN. The marketing of nicotine addiction by one oral snuff manufacturer. Tobacco Control 1995;4:73-9.
16. Hoffmann D, Djordjevic MV. Chemical composition and carcinogenicity of smokeless tobacco. Adv Dent Res 1997;11:322-9.
17. Hoffmann D, Djordjevic MV, Fan J, et al. Five leading US commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst 1995;87:1862-9.